This study investigates advanced pancreatic cancer. It looks at the combination of investigational medication with AK112.
The study evaluates the safety and effectiveness of these treatments in people with advanced pancreatic cancer.
- Who can participate: Adults with advanced pancreatic cancer who have tried 1 or 2 previous treatments may join. Participants need to have good overall health and agree to use birth control if they can have children.
- Study details: Participants will receive either the investigational medication or AK112 alone. Some may receive a placebo, an inactive substance that looks like the investigational medicine but does not contain any medicine.